The high 8-oxoG content induced microglial activation and neuronal loss, resulting in compromised cognitive function at 4–5 months of age, indicating that loss of OGG1 and MTH1 accelerates AD pathology. This evidence concerns the gene OGG1 and Alzheimer disease.